Hadox Research Labs · Science Intelligence
We watch the research landscape, compare papers with fair peers, read the full text and publish the receipts. No journal logo, citation count or model gets the last word alone.
Current truthThe ascendance engine is still building history. This edition is editorially selected, not algorithmically declared “rising.”
Comparison universe1,138 current candidates across 41 age, field and article-type cohorts.
Evidence gateEvery public dossier was read from an authorised full body. Abstract-only records remain ineligible.
As of25 Jul 2026
This public, sanitized index unites the observatory with Hadox's reviewed dossiers. Bibliographic metadata and measured signal states are visible; abstracts and source text are not.
Tracking is not endorsement. A row means Hadox is monitoring the paper or has completed a public dossier. Radar states appear only when measured against age-, field- and article-type peers; no metric is invented for editorial selections.
Read the selection method| Paper | Field | Radar state | Attention | Next review | Hadox |
|---|---|---|---|---|---|
| Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer The New England Journal of Medicine · 2026-04-02 · 10.1056/nejmx260006 | Oncology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 26% · 19 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| U.S. blockade hits Cuba’s health care and science Science · 2026-04-02 · 10.1126/science.aeh6873 | Sociology and Political Science Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 27% · 13 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| A recipe for chaos: Extrachromosomal DNA and the hallmarks of cancer Cell · 2026-04-01 · 10.1016/j.cell.2026.03.011 | Cancer Research Research article | Baseline Candidate · 1 signal point | 2 citations Cohort 30% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Amadou Sall: virologist committed to vaccine equity The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00762-2 | Health Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 40% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Asbestos, talc, and The Lancet's 1977 publication The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00558-1 | Pulmonary and Respiratory Medicine Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 62% · 13 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Atomic unification in molecular AI Cell · 2026-04-01 · 10.1016/j.cell.2026.03.010 | Materials Chemistry Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 31% · 8 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Bringing the genetically minimal cell to life on a computer in 4D Cell · 2026-04-01 · 10.1016/j.cell.2026.02.009 | Mechanical Engineering Research article | Baseline Candidate · 1 signal point | 16 citations Cohort 90% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Bringing the genetically minimal cell to life on a computer in 4D Cell · 2026-04-01 · 10.1016/j.cell.2026.04.003 | Mechanical Engineering Research article | Baseline Candidate · 1 signal point | 7 citations Cohort 70% · 5 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Cancer ecosystems: A dynamic interplay across scales Cell · 2026-04-01 · 10.1016/j.cell.2026.03.003 | Physical Sciences Research article | Baseline Candidate · 1 signal point | 6 citations Cohort 90% · 103 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Cancer, climate change, fossil fuels, and war: a call for action The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00592-1 | Reproductive Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 44% · 9 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Cell-type-specific transposon demethylation and TAD remodeling in aging mouse brain Cell · 2026-04-01 · 10.1016/j.cell.2026.02.015 | Molecular Biology Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 40% · 67 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Citrate clearance is a major function of aconitase 2 in the canonical TCA cycle Cell · 2026-04-01 · 10.1016/j.cell.2026.01.028 | Molecular Biology Research article | Baseline Candidate · 1 signal point | 3 citations Cohort 65% · 67 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Clinical phenotyping improves choices of biologics in asthma The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00140-6 | Physiology Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 29% · 12 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Complete biosynthesis of nicotine Cell · 2026-04-01 · 10.1016/j.cell.2026.03.034 | Molecular Biology Research article | Baseline Candidate · 1 signal point | 7 citations Cohort 87% · 67 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| David George Legge The Lancet · 2026-04-01 · 10.1016/s0140-6736(26)00716-6 | Neurology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 33% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
These are the exact visual editions already shared by Hadox. Each one now has a canonical source, immutable assets and a visible workflow state; publication history never substitutes for scientific review.
01
The source is identified, but no authorised full body is available for Hadox review yet.
02
Published edition linked to a full-text Hadox evidence dossier.
03
This official-source story is awaiting the institutional evidence workflow.
Historical copy retained; correction logged in the workflow.
Today, 0 papers have enough history for a momentum score and 0 public dossiers were selected by an open ascendance gate. That is not a failure to hide; it is the calibration state.
current paper assessments from Crossref + Openalex
cohorts split by paper age, article type and discipline
baseline · 1 watch · 0 rising
01Observe attention against fair peers.
02Wait for enough history to measure velocity.
03Read the authorised full paper and map every claim.
04Make a separate editorial decision and publish the evidence.